| Typicality: | 0.425 |
| Saliency: | 0.259 |
| subject → be compared to → placebo | 12 |
| subject → be compared with → placebo | 6 |
| subject → be compared to → the placebo group | 4 |
| negative | neutral | positive |
| 0.103 | 0.629 | 0.267 |
| Raw frequency | 22 |
| Normalized frequency | 0.259 |
| Modifier score | 0.700 |
| Perplexity | 78.030 |